Announcements Trials

Browse Landscape

Phase

Phase 4 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 55 Carcinoma, Hepatocellular 40 Neoplasms 38 Polycystic Ovary Syndrome 27 Colorectal Neoplasms 24 Stomach Neoplasms 21 Precursor Cell Lymphoblastic Leukemia-Lymphoma 17 Prostatic Neoplasms 16 Carcinoma, Non-Small-Cell Lung 16 Recurrence 13 Pancreatic Neoplasms 13 Lymphoma 13 Liver Neoplasms 13 Urinary Bladder Neoplasms 11 Leukemia, Myeloid, Acute 11 Esophageal Neoplasms 11 Leiomyoma 10 Colonic Neoplasms 10 Pain 9 Lung Neoplasms 9 Multiple Myeloma 8 Uterine Cervical Neoplasms 7 Neoplasm Metastasis 7 Lymphoma, Non-Hodgkin 7 Lymphoma, Follicular 7 Keratosis, Actinic 7 Infertility 7 Papillomavirus Infections 6 Pain, Postoperative 6 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 6

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Unknown × ER+ Breast Cancer × Clear all

NCT05525481 2023-11-01

PREDICTAM

Erasmus Medical Center

Phase 4 Unknown

ER+ Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡